Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of carvedilol tablets under fed conditions
TCTR20250409002Phase 1Completed
- Sponsor
- T.O. Chemicals
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of carvedilol (2 arms), sponsored by T.O. Chemicals. Primary endpoints: Maximum carvedilol plasma concentration and Area under the time-concentration curve. Started Apr 2025; status: completed.
02
Drugs
carvedilol
Beyond the preview
Go deeper on TCTR20250409002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250409002.